1.Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:18001.
2.Orange DE, Blachere NE, DiCarlo EF, Mirza S, Pannellini T, Jiang CS, et al. Rheumatoid Arthritis Morning Stiffness Is Associated With Synovial Fibrin and Neutrophils. Arthritis Rheumatol. 2020;72(4):557–64.
3.Hyldgaard C, Hilberg O, Pedersen AB, Ulrichsen SP, Lokke A, Bendstrup E, et al. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis. 2017;76(10):1700–6.
4.Blum A, Adawi M. Rheumatoid arthritis (RA) and cardiovascular disease. Autoimmun Rev. 2019;18(7):679–90.
5.Bustamante MF, Garcia-Carbonell R, Whisenant KD, Guma M. Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther. 2017;19(1):110.
6.Falconer J, Murphy AN, Young SP, Clark AR, Tiziani S, Guma M, et al. Review: Synovial Cell Metabolism and Chronic Inflammation in Rheumatoid Arthritis. Arthritis Rheumatol. 2018;70(7):984–99.
7.Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–33.
8.Jin S, Chen H, Li Y, Zhong H, Sun W, Wang J, et al. Maresin 1 improves the Treg/Th17 imbalance in rheumatoid arthritis through miR–21. Ann Rheum Dis. 2018;77(11):1644–52.
9.Inoue K, Deng Z, Chen Y, Giannopoulou E, Xu R, Gong S, et al. Bone protection by inhibition of microRNA–182. Nat Commun. 2018;9(1):4108.
10.Chen Y, Wang X, Yang M, Ruan W, Wei W, Gu D, et al. miR–145–5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin. Med Sci Monit. 2018;24:5292–300.
11.Su CM, Huang CY, Tang CH. Characteristics of resistin in rheumatoid arthritis angiogenesis. Biomark Med. 2016;10(6):651–60.
12.Hong BK, You S, Yoo SA, Park D, Hwang D, Cho CS, et al. MicroRNA–143 and –145 modulate the phenotype of synovial fibroblasts in rheumatoid arthritis. Exp Mol Med. 2017;49(8):e363.
13.Sun Y, Sun X, Liu Z, Wang X, Li Y. MiR–338–5p suppresses rheumatoid arthritis synovial fibroblast proliferation and invasion by targeting ADAMTS–9. Clin Exp Rheumatol. 2018;36(2):195–202.
14.Wang Y, Xu N, Zhao S, Jiao T, Fu W, Yang L, et al. miR–410–3p Suppresses Cytokine Release from Fibroblast-Like Synoviocytes by Regulating NF-kappaB Signaling in Rheumatoid Arthritis. Inflammation. 2019;42(1):331–41.
15.Wang Y, Jiao T, Fu W, Zhao S, Yang L, Xu N, et al. miR–410–3p regulates proliferation and apoptosis of fibroblast-like synoviocytes by targeting YY1 in rheumatoid arthritis. Biomed Pharmacother. 2019;119:109426.
16.Jiang Q, Cheng L, Ma D, Zhao Y. FBXL19-AS1 exerts oncogenic function by sponging miR–431–5p to regulate RAF1 expression in lung cancer. Biosci Rep. 2019;39(1).
17.Kong Q, Han J, Deng H, Wu F, Guo S, Ye Z. miR–431–5p alters the epithelial-to-mesenchymal transition markers by targeting UROC28 in hepatoma cells. Onco Targets Ther. 2018;11:6489–503.
18.Huang W, Zeng C, Hu S, Wang L, Liu J. ATG3, a Target of miR–431–5p, Promotes Proliferation and Invasion of Colon Cancer via Promoting Autophagy. Cancer Manag Res. 2019;11:10275–85.
19.Hu YT, Li XX, Zeng LW. Circ_0001742 promotes tongue squamous cell carcinoma progression via miR–431–5p/ATF3 axis. Eur Rev Med Pharmacol Sci. 2019;23(23):10300–12.
20.Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–81.
21.Evangelatos G, Fragoulis GE, Koulouri V, Lambrou GI. MicroRNAs in rheumatoid arthritis: From pathogenesis to clinical impact. Autoimmun Rev. 2019;18(11):102391.
22.Peng JS, Chen SY, Wu CL, Chong HE, Ding YC, Shiau AL, et al. Amelioration of Experimental Autoimmune Arthritis Through Targeting of Synovial Fibroblasts by Intraarticular Delivery of MicroRNAs 140–3p and 140–5p. Arthritis Rheumatol. 2016;68(2):370–81.
23.Wu J, Fan W, Ma L, Geng X. miR–708–5p promotes fibroblast-like synoviocytes’ cell apoptosis and ameliorates rheumatoid arthritis by the inhibition of Wnt3a/beta-catenin pathway. Drug Des Devel Ther. 2018;12:3439–47.
24.Han X, Wang X, Li H, Zhang H. Mechanism of microRNA–431–5p-EPB41L1 interaction in glioblastoma multiforme cells. Arch Med Sci. 2019;15(6):1555–64.
25.Schimmer AD. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res. 2004;64(20):7183–90.
26.Huang X, Wang XN, Yuan XD, Wu WY, Lobie PE, Wu Z. XIAP facilitates breast and colon carcinoma growth via promotion of p62 depletion through ubiquitination-dependent proteasomal degradation. Oncogene. 2019;38(9):1448–60.
27.Yu Y, Jin H, Xu J, Gu J, Li X, Xie Q, et al. XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIbeta mRNA stability. Int J Cancer. 2018;142(10):2040–55.
28.Emery IF, Gopalan A, Wood S, Chow KH, Battelli C, George J, et al. Expression and function of ABCG2 and XIAP in glioblastomas. J Neurooncol. 2017;133(1):47–57.
29.Wen X, Han XR, Fan SH, Zhang ZF, Chen L, Yi G, et al. Down-regulation of XIAP enhances the radiosensitivity of esophageal cancer cells in vivo and in vitro. Biosci Rep. 2017;37(5).
30.Moreno-Martinez D, Nomdedeu M, Lara-Castillo MC, Etxabe A, Pratcorona M, Tesi N, et al. XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells. Oncotarget. 2014;5(12):4337–46.